Additionally, we found no significant alterations of p-ERK1/2, p-JNK1/2 and p-P38 in RASD1-overexpressing glioma cells by antibody array (Supplementary Table 1), which paralleled the insignificant effects of RASD1 overexpression on glioma cell proliferation. The gene discussed is MAPK3; the disease is central nervous system cancer.